ColoAd1-1003: A Phase I Multicenter, Open Label Study of Enadenotucirev Combined With PD-1 Inhibitor in Subjects With Metastatic or Advanced Epithelial Tumors

February 18, 2019
https://clinicaltrials.gov/ct2/results?id=NCT02636036
Cancer - Colorectal, Cancer - Bladder, Cancer - Head and Neck, Cancer - Kidney
Principal Investigator: Ding Wang, MD
Cancer, Phase I, Phase 1, epithelial tumors, advanced epithelial tumors, metastatic, colorectal cancer, colorectal, bladder, Head and Neck, Renal Cancer, Renal Cell Cancer
Open